PHARMACEUTICAL
INDUSTRY
FEBRUARY 2022
WHY MOROCCO?
LEADING THE AFRICAN PHARMA
AN EXCELLENCE READY TO TACKLE THE INDUSTRY’S
INDUSTRY AND GIVING ACCESS
DRIVEN INDUSTRY FUTURE CHALLENGES
TO MAJOR PHARMA MARKETS
• Industry of excellence for more • More than 1,7 billion $ turnover • Production of Covid-19 vaccines
than 60 years • Exports to 31 african countries • Development and manufacturing of
• Aligned with international quality • Competitive platform new medicines
standards & classified European zone • Vision to support the decarbonization
(EU/WHO, GMP, ICH, ISO) of the industry
• Continuously investing to support local
manufacturing of quality drugs
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
AN INDUSTRY OF EXCELLENCE
FOR OVER 60 YEARS First R&D projects
with international
expansion
Regulatory 2010
supervision of drug
Investment growth and 2020
operating conditions
multiplication of local
capabilities
1960 2000
1965 1980
Start of export
development
Start of local
manufacturing
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
PHARMACEUTICAL INDUSTRY AT A GLANCE
KEY FIGURES KEY STRENGTHS
THEY TRUST MOROCCO
1,7 Billion $ in total Internationally recognized
turnover quality of production
Wide range of products
55,000 jobs
covering all therapeutic areas
17% of the national Highly qualified and
production exported cost-effective human capital
Over 450 million units
Modern and reliable
produced per year
production facilities
(excluding export)
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
MEETING INTERNATIONAL
QUALITY STANDARDS
Moroccan pharmaceutical industry National pharmaceutical laboratories
classified in the « Euro Zone » registered and certified by the most strict
by the World Health Organization health authorities
EudraGMDP
National Drug Quality Control Laboratory Continuous investments to support local
« LNPM » prequalified by the WHO and manufacturing of quality drugs:
accredited by the European Directorate for Nearly 110 Millions $ / Year Investments
the Quality of Medicines « EDQM » in industrial facilities
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
COMPETITIVE ACCESS TO
MAJOR PHARMA MARKETS
1st worldwide Pharma market: 2nd worldwide Pharma market: 19.1 Bn $ market size
507.7 Bn $ 235.6 Bn $
6 to 10 days transportation
10 days transportation by sea 1 day transportation by land by sea
2006 - Free Trade Agreement 2000 - Free Trade Agreement 2019 - African continental Free
Morocco - USA Morocco - EU Trade Agreement (AfCFTA)
Source: IQVIA Market Prognosis / IQVIA Institute
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
WORLD-CLASS R&D INFRASTRUCTURE
Moroccan Foundation for Advanced Science, Innovation and Research
+ 190 + 200 +700
Patents Scientists and publications
The MAScIR Foundation is a moroccan
researchers
non-profit association and a cutting-edge
scientific platform that promotes and develops
technological research centers in the fields of
biotechnology, life sciences, microelectronics,
as well as materials and nanomaterials. Its
7 + 100
start-ups projects
missions are oriented towards applied research
and innovation to meet market needs.
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
AGILE RESPONSE TO COVID-19 PANDEMIC
COVID-19 TESTING & MEDICINE EMPLOYMENT
TREATMENTS VACCINATION STOCKS
Continuous Active participation Optimal Preservation of
availability of in vaccine management pharmaceutical
Covid-19 treatment clinical trials and of security stocks sector jobs
medicines and manufacturing of limiting the risks throughout the
equipments screening kits of shortages pandemic crisis
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
READY TO TACKLE THE INDUSTRY’S
FUTURE CHALLENGES
Morocco as a major production platform for Covid-19 vaccine
His Majesty King Mohammed VI chaired on July
5th, 2021 the signing ceremony of agreements
related to Covid-19 vaccin manufacturing project
in Morocco.
This project aims to guarantee the Kingdom’s
self-sufficiency and to make Morocco a leading
biotechnology platform on the African continent.
• 500 million $ overall Investment
• 5 million production capacity per month
before gradually increasing
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
MOROCCO EXPERTISE AND KNOW-HOW
FOCUS ON SENSYO PROJECT
His Majesty King Mohammed VI chaired on January, 27th, 2022
the launching ceremony of the works for the realization of a
manufacturing plant for Covid-19 and other vaccines.
Named “SENSYO Pharmatech”, the industrial unit, the largest
platform by capacity of Fill & Finish of vaccines in Africa, will
eventually become one of the first 5 in the world.
The investment amount is between 400-500 million € ($445
million-$557 million) to ensure the production of active substances
for more than 20 vaccines, three of which would be against
coronavirus... to cover 70 % of the kingdom’s needs and more than
60% of needs across Africa.
The project aims to position Morocco as a key biotechnology
hub in Africa by integrating pharmaceutical research, clinical
development, manufacturing and marketing of biopharmaceutical
products of great necessity.
PHARMACEUTICAL INDUSTRY FEBRUARY 2022
